Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
Authors:
Open Access
- 30 March 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (24) , 16822-16831
Abstract
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patientsKeywords
This publication has 21 references indexed in Scilit:
- Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trialThe Lancet Haematology, 2017
- Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC + HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS)Blood, 2016
- High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trialThe Lancet Haematology, 2016
- Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trialThe Lancet Haematology, 2016
- Trends in primary central nervous system lymphoma incidence and survival in the U.S.British Journal of Haematology, 2016
- Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-OncologyThe Lancet Oncology, 2015
- R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphomaBlood, 2015
- Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)Journal of Clinical Oncology, 2013
- Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS LymphomaJournal of Clinical Oncology, 2006
- Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group ExperienceJournal of Clinical Oncology, 2003